Nuformix plc (LON:NFX)
London · Delayed Price · Currency is GBP · Price in GBX 0.1300
+0.0010 (0.78%)
Sep 25, 2026, 4:27 PM GMT
Nuformix Market Cap
Nuformix has a market cap or net worth of 3.52 million as of September 25, 2026. Its market cap has increased by 68.13% in one year.
Market Cap
3.52M
Enterprise Value
2.59M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
ChartMarket Cap Chart
Since October 16, 2017, Nuformix's market cap has decreased from 17.28M to 3.52M, a decrease of -79.61%. That is a compound annual growth rate of -16.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 3.52M | -34.51% |
| Dec 31, 2025 | 5.38M | 698.00% |
| Dec 31, 2024 | 674.17K | -72.13% |
| Dec 29, 2023 | 2.42M | 0.30% |
| Dec 30, 2022 | 2.41M | -63.56% |
| Dec 31, 2021 | 6.62M | -52.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genflow Biosciences | 10.62M |
| Solvonis Therapeutics | 7.83M |
| CRISM Therapeutics | 7.72M |
| Cizzle Biotechnology Holdings | 7.01M |
| Thalia Therapeutics | 6.95M |
| OptiBiotix Health | 6.04M |
| Theracryf | 4.78M |
| Physiomics | 2.38M |